Compare CVRX & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVRX | HYPR |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.3M | 158.8M |
| IPO Year | 2021 | 2021 |
| Metric | CVRX | HYPR |
|---|---|---|
| Price | $5.63 | $1.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $10.50 | $1.59 |
| AVG Volume (30 Days) | 311.6K | ★ 1.6M |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.02 | ★ 23.21 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $56,651,000.00 | $13,563,000.00 |
| Revenue This Year | $17.17 | $50.75 |
| Revenue Next Year | $17.69 | $29.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 10.45 | 5.22 |
| 52 Week Low | $4.37 | $0.76 |
| 52 Week High | $11.30 | $2.22 |
| Indicator | CVRX | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 52.44 | 39.37 |
| Support Level | $5.06 | $1.03 |
| Resistance Level | $5.99 | $1.39 |
| Average True Range (ATR) | 0.39 | 0.13 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 70.87 | 2.25 |
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.